MArS

MArS (Market Access & Pricing Strategy) is a highly specialized consultancy that guides pharmaceutical and medical device manufacturers through the complexities of European and global market access landscapes. Offering strategic reimbursement planning, value dossier generation, and health economic modeling, MArS helps life science companies secure optimal pricing and accelerate patient access to innovation.
Purchase from MArS on Scientist.com

Alongside the consulting practice, a set of named software platforms has been built out. mAxInsights is a market access planning tool covering clinical assessment, reimbursement codes, epidemiology and country-by-country reimbursement processes, currently available for Europe and the United States. DO-Bo drafts reimbursement dossiers from uploaded source documents using a closed language model, producing versions aligned to the US AMCP format, the EU joint HTA process and the German AMNOG procedure. Moolya-AI assembles payer intelligence on expectations, willingness-to-pay thresholds and competitive reimbursement landscapes, while EvinHub supports evidence generation from real-world healthcare data. Training is handled by Q-BO, which scores text or audio practice sessions for pitches and negotiations, and by Wafle, a virtual reality platform that puts teams into simulated payer and healthcare professional conversations. The advisory side runs from early planning and evidence generation through submissions, payer engagement and price negotiation.

Back to Innovation Hub